Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 379-382

  Leygue, E ^a   Dotzlaw, H ^a   Watson, P H ^a   Murphy, L C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; Progesterone receptor; Tumour progression; Variant mRNA

Indexed keywords

MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST REDUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION;

EID: 0032950159     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690366     Document Type: Article

References (19)

1. Clark GM, McGuire WL, Hubay CA, Pearson OH and Marshall JS (1983) Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 309: 1343-1347
2. Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, Ohlsson-Wilhem BM and Satyaswaroop PG (1987) Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 121: 1123-1132
3. Daffada AA, Johnston SRD, Nicholls J and Dowsett M (1994) Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J Mol Endocrinol 13: 265-273
4. Fuqua SA, Fitzgerald SD, Chamness Gc, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW and McGuire WL (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51: 105-109
5. Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL and McGuire WL (1992) Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52: 483-486
6. Hiller T, Snell L and Watson PH (1996) Microdissection/RT-PCR analysis of gene expression. Biotechniques 21: 38-44
7. Horwitz KB, McGuire WL, Pearson OH and Segaloff A (1975) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726-727
8. Horwitz KB, Koseki Y and McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103: 1742-1751
9. Horwitz KB, Tung L and Takimoto GS (1995) Novel mechanisms of antiprogestin action. J Steroid Biochem Mol Biol 53: 9-17
10. Huang A, Leygue E, Snell L, Murphy LC and Watson PH (1997) Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol 150: 1827-1833
11. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 9: 1603-1614
12. Leygue E, Dotzlaw H, Watson PH and Murphy LC (1996a) Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun 228: 63-68
13. Leygue E, Watson PH and Murphy LC (1996b) Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 88: 284-290
14. McGuire WL, Chamness GC and Fuqua SA (1991) Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571-1577
15. Murphy LC, Leygue E, Dotzlaw H, Douglas D, Coutts A and Watson PH (1997) Oestrogen receptor variants and mutations in human breast cancer. Ann Med 29: 221-234
16. Richer JK, Lange CA, Wierman AM, Brooks KM, Tung L, Takimoto GS and Horwitz KB (1998) Progesterone receptor variants found in breast cells repress transcription by wild-type receptors. Breast Cancer Res Treat 48: 231-241
17. Tsai MJ and O'Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486
18. Wang Y and Miksicek RJ (1991) Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 5: 1707-1715
19. Yeates C, Hunt SM, Balleine RL and Clarke CL (1998) Characterization of a truncated progesterone receptor protein in breast tumors. J Clin Endocrinol Metab 83: 460-467